Benefit From Anti-EGFRs in RAS and BRAF Wild-Type Metastatic Transverse Colon Cancer: A Clinical and Molecular Proof of Concept Study

ESMO Open - United Kingdom

doi 10.1136/esmoopen-2019-000489